Qisda (TWSE: 2352) today announces that the Board of Directors has approved a tender offer to acquire 13.95% outstanding common shares of NORBEL BABY (stock code: 6844, hereafter referred to as NORBEL) at NT$175 per share in cash. This move aims at strengthening its presence in the medical retail channel market and seize the opportunity in the elderly market. Through this tender offer, both companies will utilize each other’s resources to jointly expand the territory of the medical retail distribution channel market.

The tender offer will be submitted to the Financial Supervisory Commission (FSC) and then announced to the public. The filing date is expected no later than September 24, 2024 and the expected start date of the tender offer is no later than September 25, 2024. The maximum number of shares to be acquired is 5,220,000, representing approximately 13.95% of NORBEL’s outstanding common shares, while the minimum is 1,872,000, or approximately 5% of NORBEL’s outstanding common shares. The tender offer will be deemed successful while the validly tendered shares meet the minimum threshold and the Fair Trade Commission does not prohibit the merger between Qisda and NORBEL.

Qisda Chairman, Peter Chen, stated that the healthcare business is one of the major pillars in Qisda’s transformation into a high-value-added enterprise. With BenQ Medical Center as the flagship for medical services, fueled by the dual growth engines of medical devices and pharmaceutical distribution, Qisda aims to offer comprehensive services that promote healthier aging in response to the global trend of aging populations. Qisda currently holds approximately 26.72% of NORBEL’s shares and intends to increase its stake to further strengthen its strategic positioning.

NORBEL specializes in the sales of professional pharmaceuticals, medical care, health care, maternity and infant products, medical beauty products, and related consulting services. Operating under the brand name "Tin Tin Drugstore," NORBEL has established a network of 94 large-scale professional chain pharmacies and drugstores across Taiwan. NORBEL employs over a hundred highly trained, full-time pharmacists, each with an average of more than five years of experience.